Biocon Limited has informed the Exchange regarding a press release dated February 29, 2024, titled "Press Release titled Biocon Biologics Secures US Market Entry Date for Bmab 1200, a Proposed Biosimilar to Stelara��".
Biocon Limited has informed the Exchange regarding a press release dated February 29, 2024, titled "Press Release titled Biocon Biologics Secures US Market Entry Date for Bmab 1200, a Proposed Biosimilar to Stelara��".